Good, but not fantastic. Will have to wait until mid year for the final results. I would've liked more info in regards to the "moderate" adverse effects alluded to in the update.
Point is that cannabinoids work for a good proportion of patients....some tough times ahead for MC patients, clinicians wont jump on the MC band wagon just yet.
Ann: PhytoTech Therapeutics Phase 2 Clinical Trial Update, page-4
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add HGV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.412M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 35637 | 4.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.4¢ | 39163 | 2 |
View Market Depth
| Last trade - 11.00am 22/08/2024 (20 minute delay) ? |
| HGV (ASX) Chart |
Day chart unavailable